Customer Reviews for Celadrin® Advanced Joint Health Cream, 170 Grams

Fast Acting Advanced Pain Relieving Cream Works in 30 minutes or less   Penetrating relief for sore muscles and joints   Greaseless formulation   Safe and effective   Clinically proven   No reported side effects   FIMS Approved^ Clinically Tested. Shown to Work. Patented Ingredients. Get Going, Get Active, Get Celadrin Celadrin® Pain Relieving Cream can be used safely and with confidence.  Use Celadrin  topical cream to temporarily relieve the aches and pains of sore muscles and joints. Celadrin's published studies can be found in journals like the prestigious Journal of Rheumatology (April 2004, Vol 31). Published randomized, double-blind, placebo controlled, U.S. clinical studies concluded that Celadrin topical cream showed: Significant improvement in timed stair climbing, timed up and go, flexibility, range of motion and physical endurance tests in just 30 minutes with continuous improvement over the next 30 days. 1, 2, 3   100% of the subjects on Celadrin's topical cream received significant benefit compared to the placebo. 1   Indications: For temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains. Directions: Adults and children 2 years of age and older : Apply to affected area not more than 3 to 4 times per day.   Children under 2 years of age: Consult a physician. Active Ingredient - Purpose:   Menthol (1.25%) - Topical Analgesic. Inactive Ingredients: Benzyl Alcohol, Butylparaben, Carbomer, Celadrin® (a proprietary blend of esterified fatty acid carbons), Ethylparaben, Glycerin, Glyceryl Stearate, Isobutylparaben, Lecithin, Methylparaben, Olea Europaea (Olive) Fruit Oil, PEG-100 Stearate, Peppermint Oil, Phenoxyethanol, Potassium Hydroxide, Propylparaben, Tocopheryl Acetate, Water Warnings: For external use only.   Avoid contact with eyes.   If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of product and consult a physician.   Do not apply to wounds or damaged skin.   Do not bandage tightly.   Keep out of reach of children.    If swallowed, get medical help or contact a poison control center right away. Other Information: Store in a cool, dry place. ©2006, Imagenetix • Made in U.S.A. • U.S. Patent #5,569,676 Celadrin® is a registered trademark of Imagenetix, Inc. ^The International Federation of Sports Medicine (FIMS www.fims.org) goal since 1920 has been to provide the best medical care for Olympic athletes. FIMS has endorsed Celadrin, its first and only Official Joint and Muscle Cream, for sports enthusiasts and active adults around the world. As part of its goal to provide the most advanced technologies in sports medicine, FIMS supports the strong performance of Celadrin topical cream for the training and rehabilitation regimen of any athlete from novice to world class in order to maximize their achievements. 1 Kraemer W.J., Ratamess N.A., Anderson J.A., Maresh C.M., Tiberio D.P., Joyce M.E., Messinger B.N., French D.N., Sharman M.J., Rubin M.R., Gomez A.L., Volek J.S. and Hesslink, Jr., R.L. (2004) The Effects Of A Cetylated Fatty Acid (Celadrin) Topical Cream On Functional Mobility And Quality Of Life Of Patients With Osteoarthritis.  J. Rheumatology, 31(4):767-74 2 Kraemer W.J., Ratamess N.A., Maresh C.M., Anderson J.A., Volek J.S., Tiberio D.P., Joyce M.E., Messinger B.N., French D.N., Sharman M.J., Rubin M.R., Gomez A.L., Silvestre R, and  Hesslink, Jr., R.L. (2005). A Cetylated Fatty Acid (Celadrin) Topical Cream With Menthol Reduces Pain and Improves Functional Performance In Individuals With Arthritis. J Strength Cond Res. 19(2):475-480. 3 Kraemer W.J., Ratamess N.A., Maresh C.M., Anderson J.A., Tiberio D.P., Joyce M.E., Messinger B.N., French D.N., Sharman M.J., Rubin M.R., Gomez A.L., Volek J.S., Silvestre R, and  Hesslink, Jr., R.L. (2005). Effects of Treatment With a Cetylated Fatty Acid (Celadrin) Topical Cream on Static Postural Stability and Plantar Pressure Distribution in Patients With Knee Osteoarthritis. J Strength Cond Res. 19(1):115-121.